Chronic lymphocytic leukemia (CLL)
- Observe asymptomatic early CLL until treatment criteria are met
- Targeted oral therapy has largely replaced routine chemoimmunotherapy
- BTK inhibitor or venetoclax-based regimen are major options
- TP53/del17p strongly affects choice
- Prevent/treat infection and hypogammaglobulinemia when needed
- Do not treat lymphocyte count alone
Use at a glance
- Observe asymptomatic early CLL until treatment criteria are met
Treatment options
- Targeted oral therapy has largely replaced routine chemoimmunotherapy
- BTK inhibitor or venetoclax-based regimen are major options
- TP53/del17p strongly affects choice
Choosing treatment
- Prevent/treat infection and hypogammaglobulinemia when needed
Safety / pitfalls
- Do not treat lymphocyte count alone
Self-check
- When should treatment begin for asymptomatic early CLL in Chronic lymphocytic leukemia (CLL)?
treatment.
Drugs used for this (2)
All clinical uses · Open the interactive console ↗
